U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07855627) titled 'Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance Measurements' on Sept. 29.
Brief Summary: To find out whether the BIA test can help identify participants with IBC who are at risk for developing lymphedema.
Study Start Date: Sept. 16
Study Type: OBSERVATIONAL
Condition:
Lymphedema
Inflammatory Breast Cancer (IBC)
Preoperative
Bioimpedance Measurement
Intervention:
DRUG: Neoadjuvant therapy
all patients will start/continue neoadjuvant systemic therapy
Recruitment Status: RECRUITING
Sponsor: M.D. Anderson Cancer Center
Published by HT Digital Content Services with permission ...